Skip to main content
Premium Trial:

Request an Annual Quote

Philip Morris Gives NC State $17.6 Million to Tackle Tobacco Genome

NEW YORK, Dec. 12-Philip Morris will underwrite the sequencing of the tobacco genome at North Carolina State University, the school said yesterday.


The tobacco company will provide the university with $17.6 million during the next four and a half years in order to create a tobacco genome map.


The Tobacco Genome Initiative will be lead by Charles Opperman, a plant pathologist and geneticist at NC State. Research will be done in his lab and at the university's new Genome Research Laboratory at the College of Agriculture and Life Sciences.


Opperman's team will also work with St. Louis-based Orion Genomics, which will supply its Gene Thresher gene identification technology.


This contract is among the largest the university has ever signed.


Philip Morris said it was funding the project in the hopes of ultimately developing less dangerous strains of tobacco.


The plant is also used as a model organism in botanical research.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.